We did it. We won.

You may recall that in March 2020, a private prison company sued Candide Group (and our co-founder, Morgan Simon) for defamation regarding our activism in opposition to family separation at the US-Mexico border. We didn't think it was right that big banks were funding private prisons, profiting off of immigrant detention and mass incarceration. So we did something about it.

It is with great pleasure that we write to inform you that the case is finally over and that the truth proved victorious: we won!

Candide Group was a leading partner on the Families Belong Together corporate accountability committee. Together, we launched a campaign to pressure banks against financing the family separation crisis in 2018/19. With over 500,000 activists participating, we succeeded: over 87% of CoreCivic and GEO Group's funding evaporated. This led to, in CoreCivic's own estimation, as much as $60M in losses.

The 9th Circuit's recent ruling has affirmed that our campaigns were effective, not illegal. Sometimes the truth just hurts!

We are deeply grateful for the support of our community of activists, the lawyers of Davis Wright Tremaine, and, of course, all of your support! The Families Belong Together campaign is proof that where we put our money matters. We are so blessed to work with you and appreciate your continued focus on putting money to work for good.

This saga has been a long one in part because CoreCivic kept appealing each decision along the way. After the first judge affirmed that prisons do, in fact, separate families, we wrote an initial Medium post explaining the campaign, the lawsuit, and the power of financial activism. With what we hope and believe will be the final development in this tale, we have updated that piece to reflect our November 2022 victory.

Did an awesome human forward you this newsletter? Sign up for Candide Group's mailing list here.

Follow us on Twitter or visit CandideGroup.com for more!

View our list of past specific recommendations for the last 12 months. For more information about Candide, please see our Form ADV, Part 2A.

Disclosure: The information contained in this document is intended for educational and information purposes only and should not be considered investment tax or legal advice or a recommendation to buy or sell any particular security. Please consult with your tax and legal advisors regarding your particular circumstances.Certain statements contained herein may constitute projections, forecasts, and other forward-looking statements, which do not reflect actual results and are based primarily upon a hypothetical set of assumptions applied to certain historical financial information. Certain information has been provided by third-party sources, and, although believed to be reliable, it has not been independently verified, and its accuracy or completeness cannot be guaranteed.Any opinions, projections, forecasts, and forward-looking statements presented herein are valid as of the date of this document and are subject to change.The investment discussed herein have been included based on the following methodology: all investments Candide Group has facilitated on behalf of our clients since the publishing of our last all-network newsletter, and investments with recent public news events. For a complete list of all investments, please click the “list of past specific recommendations for the last 12 months” link above. The views and opinions are those of the author as of the date of publication and are subject to change at any time. This material represents an assessment of the market environment at a specific point in time and is not intended to be a forecast of future events, or a guarantee of future results. Candide Group is under no obligation to update this information after the date of this publication.Past performance is not indicative of future results; no representation is being made that any investment will or is likely to achieve profits or losses like those achieved in the past, or that significant losses will be avoided. An investor should consider the investment objectives, risks, charges and expenses of any financial product carefully before investing. Investing involves various risks, including loss of principal. Charts and graphs provided herein are for illustrative purposes only. For more information about Candide, please see our Form ADV, Part 2A.